資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com
IHS_EWBIEEE xploreSTRATEGY ANALYTICSIHS_EWB_GF

頁面路徑選單

Ureteroscope Market Research Report by Type, Usage, Application, End User, Country - North America Forecast to 2027 - Cumulative Impact of COVID-19

  • LinkedIn
  • facebook
  • Twitter
出 版 商:360iResearch LLP
出版日期:2022/10/11
頁  數:144頁
文件格式:PDF
價  格:
USD 3,449 (Single-User License)
USD 4,949 (Multi-User License)
USD 5,949 (Global-User License)
線上訂購或諮詢
國  家:North America Canada Mexico United States California Florida Illinois New York Ohio Pennsylvania Texas
The North America Ureteroscope Market size was estimated at USD 269.63 million in 2021 and expected to reach USD 281.00 million in 2022, and is projected to grow at a CAGR 2.57% to reach USD 314.03 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Ureteroscope to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Flexible Ureteroscopes, Rigid Ureteroscopes, and Semirigid Ureteroscopes.

Based on Usage, the market was studied across Multi-Use and Single-Use/Disposable.

Based on Application, the market was studied across Diagnostic Applications and Therapeutic Applications.

Based on End User, the market was studied across Ambulatory Surgical Centers, Diagnostic Imaging Centers, Hospitals, and Specialty Clinics.

Based on Country, the market was studied across Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Ureteroscope market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Ureteroscope Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the North America Ureteroscope Market, including Advin Health Care, Biomerics, Boston Scientific Corporation, Dornier MedTech GmbH, E.M.S. Electro Medical Systems S.A., ELMED Medical Systems, Karl Storz Medical AG, Maxer Endoscopy GmbH, Obex, Olympus Corporation, OPCOM, PENTAX Medical, Prosurg Inc., Richard Wolf GmbH, Rocamed, SCHÖLLY FIBEROPTIC GMBH, Stryker Corporation, and Vimex Sp. z o.o.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the North America Ureteroscope Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the North America Ureteroscope Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the North America Ureteroscope Market?
4. What is the competitive strategic window for opportunities in the North America Ureteroscope Market?
5. What are the technology trends and regulatory frameworks in the North America Ureteroscope Market?
6. What is the market share of the leading vendors in the North America Ureteroscope Market?
7. What modes and strategic moves are considered suitable for entering the North America Ureteroscope Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Ureteroscope Market, by Type
6.1. Introduction
6.2. Flexible Ureteroscopes
6.3. Rigid Ureteroscopes
6.4. Semirigid Ureteroscopes

7. Ureteroscope Market, by Usage
7.1. Introduction
7.2. Multi-Use
7.3. Single-Use/Disposable

8. Ureteroscope Market, by Application
8.1. Introduction
8.2. Diagnostic Applications
8.3. Therapeutic Applications

9. Ureteroscope Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Diagnostic Imaging Centers
9.4. Hospitals
9.5. Specialty Clinics

10. Canada Ureteroscope Market
10.1. Introduction

11. Mexico Ureteroscope Market
11.1. Introduction

12. United States Ureteroscope Market
12.1. Introduction

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Advin Health Care
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Biomerics
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Boston Scientific Corporation
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Dornier MedTech GmbH
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. E.M.S. Electro Medical Systems S.A.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. ELMED Medical Systems
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Karl Storz Medical AG
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Maxer Endoscopy GmbH
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Obex
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Olympus Corporation
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. OPCOM
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. PENTAX Medical
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Prosurg Inc.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Richard Wolf GmbH
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Rocamed
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. SCHÖLLY FIBEROPTIC GMBH
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Stryker Corporation
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Vimex Sp. z o.o
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

回上頁